Reference Source

H&A HOLLAND · 66-41 · NETHERLANDS

For H&A HOLLAND, import alert is 66-41; country is NETHERLANDS; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE); product code is 23 R - - 02 Sesame Seed (Edible Seed Paste) | 37 K - - 21 Sesame Paste | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 01/05/2022; address is Stephensonstraat 10 R , Zoetermeer, Zuid-Holland NETHERLANDS, verified against its source on 2026-10-01.

Firm
H&A HOLLAND verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
NETHERLANDS verified
Address
Stephensonstraat 10 R , Zoetermeer, Zuid-Holland NETHERLANDS verified
Date published
01/05/2022 verified
Product code
23 R - - 02 Sesame Seed (Edible Seed Paste) | 37 K - - 21 Sesame Paste | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
Product
MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE) each item verified
FDA notes
The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

H&A HOLLAND Date Published : 01/05/2022 Stephensonstraat 10 R , Zoetermeer, Zuid-Holland NETHERLANDS

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Product code, Product and FDA notes

23 R - - 02 Sesame Seed (Edible Seed Paste) Date Published: 01/05/2022 Desc: MAZI TAHIN (SESAME PASTE) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. 37 K - - 21 Sesame Paste Date Published: 01/05/2022 Desc: MAZI TAHIN (SESAME PASTE) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 01/05/2022 Desc: MAZI TAHIN (SESAME PASTE) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’.

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.